Literature DB >> 23101691

Nucleic acid-based methods to assess the composition and function of the bowel microbiota.

Blair Lawley1, Gerald W Tannock.   

Abstract

This article describes nucleic acid-based methods to assess the composition and function of the bowel microbiota. The methods range from the relatively simple (polymerase chain reaction) to the technically sophisticated (metatranscriptomics). Not all are accessible to the majority of laboratories, but a core of validated (used in more than 1 study) tools is readily available to most researchers. Reliance on a single methodology per human study is not recommended. Generally, a study could commence with a screening of samples to determine whether it will be worthwhile expending further time and money on an in-depth analysis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101691     DOI: 10.1016/j.gtc.2012.08.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  3 in total

Review 1.  The intestinal microbiome in early life: health and disease.

Authors:  Marie-Claire Arrieta; Leah T Stiemsma; Nelly Amenyogbe; Eric M Brown; Brett Finlay
Journal:  Front Immunol       Date:  2014-09-05       Impact factor: 7.561

2.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

3.  The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing.

Authors:  Nicholas A Kennedy; Alan W Walker; Susan H Berry; Sylvia H Duncan; Freda M Farquarson; Petra Louis; John M Thomson; Jack Satsangi; Harry J Flint; Julian Parkhill; Charlie W Lees; Georgina L Hold
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.